名称及编号 |
实验药物 |
研究名称 |
研究时间 |
回顾性研究 #000 |
Pandimex IV |
Careseng Vancouver Naturopathic Clinic,
Vancouver, BC, Canada |
2000 – 2004 |
临床试验 #001 |
Careseng oral formulation |
Harbor-UCLA Medical Center, Torrance, California, USA |
Jun 2002 – Suspended |
临床试验 #002 |
Pandimex IV |
Fuzhou General Hospital, China |
Apr 2004 – Jul 2004 |
临床试验 #003 |
Pandimex IV |
No.1 Hospital of Yichun City, China |
Apr 2005 – Mar 2006 |
临床观察 CIH |
Careseng oral formulation |
Centre for Integrative Healing & UBC, Vancouver, BC, Canada |
Feb 2005 – Jul 2005 |
临床试验 #G01 |
Pandimex IV (HemoMex I) |
National Oncology Center, Republic of Georgia |
Apr 2007-Nov 2009 |
临床试验 #G02 |
SG2 softgel (HemoMex S) |
National Oncology Center, Republic of Georgia |
Aug 2008-Mar 2010 |
临床试验 #G03 |
SG2 softgel (HemoMex S) |
National Oncology Center, Republic of Georgia |
Aug 2008-Mar 2010 |
临床试验 # G04 |
Pandimex IV & SG2 (HemoMex I & HemoMex S) |
National Oncology Center, Republic of Georgia |
Apr 2007- Apr 2010 |
临床试验 #A01 |
SG2 softgel (HemoMex S) |
National Oncology Center , Republic of Armenia |
Oct 2009- May 2010 |
